Literature DB >> 23481610

Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation.

Ayano Takeuchi-Yorimoto1, Takahisa Noto, Atsushi Yamada, Yoichi Miyamae, Yuji Oishi, Masahiro Matsumoto.   

Abstract

Nonalcoholic steatohepatitis (NASH) is characterized by combined pathology of steatosis, lobular inflammation, fibrosis, and hepatocellular degeneration, with systemic symptoms of diabetes or hyperlipidemia, all in the absence of alcohol abuse. Given the therapeutic importance and conflicting findings regarding the potential for healing the histopathologic features of NASH in humans, particularly fibrosis, we investigated the reversibility of NASH-related findings in Wistar rats fed a choline-deficient and iron-supplemented l-amino acid-defined (CDAA) diet for 12weeks, with a recovery period of 7weeks, during which the diets were switched to a choline-sufficient and iron-supplemented l-amino acid-defined (CSAA) one. Analysis showed that steatosis and inflammation were significantly resolved by the end of the recovery period, along with decreases in AST and ALT activities within 4weeks. In contrast, fibrosis remained even after the recovery period, to an extent similar to that in continuously CDAA-fed animals. Real-time reverse transcriptase-polymerase chain reaction, Western blot, and immunohistochemical investigations revealed that expression of some factors indicating oxidative stress (CYP2E1, 4-HNE, and iNOS) were elevated, whereas catalase and SOD1 were decreased, and a hypoxic state and CD34-positive neovascularization were evident even after the recovery period, although the fibrogenesis pathway by activated α-SMA-positive hepatic stellate cells via TGF-β and TIMPs decreased to the CSAA group level. In conclusion, persistent fibrosis was noted after the recovery period of 7weeks, possibly due to sustained hypoxia and oxidative stress supposedly caused by capillarization. Otherwise, histopathological features of steatosis and inflammation, as well as serum AST and ALT activities, were recovered.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23481610     DOI: 10.1016/j.taap.2013.01.027

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  13 in total

1.  High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes.

Authors:  João S Teodoro; Ana T Varela; Anabela P Rolo; Carlos M Palmeira
Journal:  Genes Nutr       Date:  2014-05-20       Impact factor: 5.523

2.  Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.

Authors:  Lei Wang; Fu-Liang He; Fu-Quan Liu; Zhen-Dong Yue; Hong-Wei Zhao
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

3.  Effect of dietary betaine on growth performance, antioxidant capacity and lipid metabolism in blunt snout bream fed a high-fat diet.

Authors:  Jean-Jacques Yao Adjoumani; Kaizhou Wang; Man Zhou; Wenbin Liu; Dingdong Zhang
Journal:  Fish Physiol Biochem       Date:  2017-09-30       Impact factor: 2.794

4.  Influences of glycyrrhetinic acid (GA) dietary supplementation on growth, feed utilization, and expression of lipid metabolism genes in channel catfish (Ictalurus punctatus) fed a high-fat diet.

Authors:  Hesham Eed Desouky; Guang-Zhen Jiang; Ding-Dong Zhang; Kenneth Prudence Abasubong; Xiangyang Yuan; Xiang-Fei Li; Wen-Bin Liu
Journal:  Fish Physiol Biochem       Date:  2020-01-02       Impact factor: 2.794

5.  Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.

Authors:  Lee-Won Chong; Yi-Chao Hsu; Ting-Fang Lee; Yun Lin; Yung-Tsung Chiu; Kuo-Ching Yang; Jaw-Ching Wu; Yi-Tsau Huang
Journal:  BMC Gastroenterol       Date:  2015-02-15       Impact factor: 3.067

6.  M1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.

Authors:  Vikrant Rachakonda; Ravirajsinh N Jadeja; Nathalie H Urrunaga; Nirish Shah; Daniel Ahmad; Kunrong Cheng; William S Twaddell; Jean-Pierre Raufman; Sandeep Khurana
Journal:  Sci Rep       Date:  2015-09-16       Impact factor: 4.379

7.  Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus).

Authors:  Luciana L A Ventura; Nathália C L Fortes; Helton C Santiago; Marcelo V Caliari; Maria A Gomes; Dirce R Oliveira
Journal:  PeerJ       Date:  2017-03-02       Impact factor: 2.984

Review 8.  Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?

Authors:  Agnes Görlach; Elitsa Y Dimova; Andreas Petry; Antonio Martínez-Ruiz; Pablo Hernansanz-Agustín; Anabela P Rolo; Carlos M Palmeira; Thomas Kietzmann
Journal:  Redox Biol       Date:  2015-08-28       Impact factor: 11.799

Review 9.  Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.

Authors:  Jian Wu
Journal:  Oncotarget       Date:  2016-07-05

10.  Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.

Authors:  Anuradha Rao; Ivo P van de Peppel; Sanjeev Gumber; Saul J Karpen; Paul A Dawson
Journal:  Front Med (Lausanne)       Date:  2020-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.